• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • What is ALS/MND
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
      • Open Label Extension
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • Collaborative Medicinal Development – CuATSM
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • T Regulatory Cell Therapies
      • SOD1 Therapies & Trials
    • Approved Drugs
      • Neudexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Alliance Meeting
    • Allied Professionals Forum
    • Alliance Webinars
    • ALS/MND Connect
    • Global Day Calendar
    • March of Faces
    • Patient Fellows Program
    • International Symposium
  • About
    • Who We Are
    • Board of Trustees
    • Advisory Councils/Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Innovation and Technology Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Archives
      • Newsletters
      • Meetings
    • Awards
      • Student Innovation Award
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
  • Members
    • Member Registration
    • Forgot Password

Technology

Advances in technology, specifically for health and disease, have skyrocketed over the last few decades. Research and development for technology have made daily living activities and healthcare more accessible for people living with ALS/MND. However, it is important to note that not all technology is accessible to everyone and, at times, may be a barrier for certain individuals.Technological devices and equipment are constantly being developed to help with various symptoms for people living with ALS/MND. Common symptoms such as muscle weakness, loss of speech, and fatigue can make it difficult or impossible for a person with ALS/MND to achieve daily living activities. There are various options for individuals for technological aid for mobility, speech and communication, environmental controls, and access to other technology such as computers and phones. Overall, these devices are designed to improve a person’s quality of life throughout ALS/MND disease progression.There are various input modality technologies that can benefit PALS when they can no longer perform the traditional input such as using their fingers to type or speak for voice command. The various types of input can include:

  • Infrared Sensing: Use of light transmission
  • Electromyography: Using body movements such as facial expressions
  • Oculography: Eye movements used similarly to a cursor
  • Electroencephalography: Using brain signals

This list is by no means exhaustive but gives insight into the range of technological advances for people living with ALS/MND. The multidisciplinary healthcare team can be considered a resource for navigating certain technologies and finding an option that best suits individuals based on their needs.

Technology in the form of telehealth can also benefit individuals with ALS/MND. Telehealth allows for people with ALS/MND to have access to healthcare in a virtual format. This can reduce the stress and work of physical, face-to-face appointments and allow appointments to be made more easily. They may also increase accessibility for people living with ALS/MND who live in rural areas or areas where accessible public transportation is limited. Telehealth advancements are an ongoing development and are constantly being improved.

Numerous apps and at-home-technologies are available that allow people living with ALS/MND to test, track, document, and upload various aspects of their health. These apps can help people living with ALS/MND with many aspects of their lives. The use of this technology has also made for advancements in telehealth and telemedicine in which technology is used for ongoing disease progression assessments and documentation for people living with ALS/MND. These have allowed healthcare professionals to safely monitor their patients’ disease progression and can improve communication between healthcare professionals, carers, and people living with ALS/MND.

Clinical trials have also been able to make use of technology for similar purposes. This has allowed for ongoing care for people living with ALS/MND, in some cases has increased healthcare access for individuals, and also greater enrollment for clinical trials.

In addition, as new technology arises, it becomes abundantly clear that there are also barriers for certain individuals. Costs and financing for technological programs can create a divide. Age and adjustments to using technology can also prevent people living with ALS/MND from accessing or benefitting from certain advances. Discussions with the multidisciplinary healthcare team can provide more information on training for technological devices, insurance coverage in certain regions. They can also answer any other questions individuals may have.

For more information on technology, refer to the resources provided below.

Click on the icon below to visit our playlist of videos related to Technology.

The following are resources from Members of the International Alliance of ALS/MND Associations on the topic of Technology.

Free or Low Cost Apps

The MND Association (MNDA) has gathered a list of various apps available to people living with ALS/MND. Various apps for topics such as health, appointments, nutrition, and communication are provided.

https://www.mndassociation.org/support-and-information/information-resources/free-or-low-cost-apps/

Language: English
Subject Areas: Technology, Apps, For People with ALS/MND, For Caregivers, For Multidisciplinary Healthcare Team

Software Tools

The ALS Liga Belgium provides a list of different software applications that can make technology and everyday tasks more accessible for people living with ALS/MND. These include speech and communication and computer use.

https://www.als.be/en/software-tools

Language: French, German, English, Dutch
Subject Areas: Technology, Software, For People with ALS/MND, For Caregivers, For Multidisciplinary Healthcare Team

Smart Home Technology and ALS

This is a blog post written and posted by the ALS Association (ALSA). In this blog, Smart Home technologies are discussed pertaining to aids for people living with ALS/MND.

https://www.als.org/blog/smart-home-technology-and-als

Language: English
Subject Area: Technology, For People with ALS/MND, For Caregivers

Telehealth, ALS/MND, and COVID-19

This is a podcast by Connecting ALS produced by the ALS Association (ALSA). This podcast discusses the advances in telehealth, the benefits of telehealth, and concerns and issues for people with ALS/MND and access to telehealth. Note that this resource is concerning advancements in telehealth as a result of the COVID-19 pandemic. Any views or opinions presented in this podcast are solely those of the authors. They do not necessarily represent those of The ALS Association.

https://www.connectingals.org/episodes/telehealth-and-the-evolution-of-clinical-care-during-covid-19?_ga=2.72525072.2045315913.1625135551-567082341.1625135551

Language: English
Subject Area: Telehealth and Telemedicine, Technology, For Multidisciplinary Healthcare Team, For People with ALS/MND, For Caregivers

How Telemedicine is Intergrating into ALS Multidisciplinary Care

In this interview report with Dr. James Berry, provided by the ALS Association (ALSA), telemedicine is discussed. Dr. James Berry explains the benefits and uses for telemedicine and also discusses the ALS Clinic Telemedicine for People living with ALS.

https://www.als.org/blog/how-telemedicine-integrating-als-multidisciplinary-care

Language: English
Subject Area: Telehealth and Telemedicine, Technology, For Multidisciplinary Healthcare Team For People with ALS/MND, For Caregivers

Developing Technologies to Help People with ALS Live Better Lives

The ALS Association (ALSA) provides a blog post that outlines different technological advancements that are a part of the Managing ALS Research Program. A link within the blog leads to a podcast by Connecting ALS (produced by ALSA) that discusses technologies for people living with ALS/MND in more detail.

https://www.als.org/blog/als-association-furthers-commitment-develop-technologies-help-people-als-live-better

Language: English
Subject Area: Technology, Research, For People with ALS/MND, For Multidisciplinary Healthcare Team

ALS Assistive Technology Blog

Alisa Brownlee, ATP, CAPS’ blog offers recent articles and web information on ALS, assistive technology, augmentative alternative communication (AAC), computer access, and other electronic devices that can impact and improve the quality of life for people with ALS. Email abrownlee@alsa-national.org. Any views or opinions presented on this blog are solely those of the author and do not necessarily represent those of The ALS Association.

http://alsassistivetechnology.blogspot.com

Language: English
Subject areas: Equipment, Communications and Assistive Technology

Primary Sidebar

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition and Swallowing
  • Occupational Therapy and Activities of Daily Living
  • Physiotherapy and Mobility
  • Respiratory Care
  • Speech Therapy and Communication
  • Support for Family & Caregivers
  • Technology

  • Maurice Leclerc, Canada

    Maurice Leclerc, Canada

  • Lombana, Spain

    Lombana, Spain

  • Wendy Hendrickson, ALS Hope Foundation, USA

    Wendy Hendrickson, ALS Hope Foundation, USA

  • 83

    83

  • Roxana Canova, Diagnosed 2012 ,  Asociación ELA Argentina

    Roxana Canova, Diagnosed 2012 , Asociación ELA Argentina

  • Jean

    Jean
    jean

  • Peng Yi-Wen

    Peng Yi-Wen

  • Zabun Nassar, MND Association, Diagnosed 2016, England

    Zabun Nassar, MND Association, Diagnosed 2016, England

  • Antonio Ventriglia,  ALS Liga Belgium,  Diagnosed 2013

    Antonio Ventriglia, ALS Liga Belgium, Diagnosed 2013

  • Jose Rivero Muñoz, Diagnosed 2015, FYADENMAC, Mexico

    Jose Rivero Muñoz, Diagnosed 2015, FYADENMAC, Mexico

  • Tison, USA

    Tison, USA

  • Liong Ting Ngu, MND Malaysia, Diagnosed 2014

    Liong Ting Ngu, MND Malaysia, Diagnosed 2014

  • Timmy, ALS Liga

    Timmy, ALS Liga

  • Shay Rishoni, Diagnosed 2011 , Prize4Life, Israel

    Shay Rishoni, Diagnosed 2011 , Prize4Life, Israel

  • Amparo Muriel Engativa, Colombia

    Amparo Muriel Engativa, Colombia

  • Bruno Leanza Mantegna, Diagnosed 1999 , AISLA Onlus, Italy

    Bruno Leanza Mantegna, Diagnosed 1999 , AISLA Onlus, Italy

  • Anita Forte, Les Turner ALS Foundation, USA

    Anita Forte, Les Turner ALS Foundation, USA

  • Ali Var, Turkey

    Ali Var, Turkey

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Charlie “Hark” Dourney, Diagnosed 2007 , Hark ALS, USA

    Charlie “Hark” Dourney, Diagnosed 2007 , Hark ALS, USA

  • Mauril Belanger

    Mauril Belanger

  • Mike Small, Motor Neurone Disease (MND) Association, UK

    Mike Small, Motor Neurone Disease (MND) Association, UK

  • Greg Heydet, ALS Hope Foundation, USA

    Greg Heydet, ALS Hope Foundation, USA

  • Fabrice Kamp, Germany

    Fabrice Kamp, Germany

  • Bob Simonds and Drew O'Neil, USA

    Bob Simonds and Drew O’Neil, USA

  • Claudette Sturk, ALS Society of Canada

    Claudette Sturk, ALS Society of Canada
    Picture2

  • David Solomon, Diagnosed 2015, MND Association of England, Wales and N Ireland

    David Solomon, Diagnosed 2015, MND Association of England, Wales and N Ireland

  • Hollister

    Hollister
    hollister

  • Hans Dieter Olszewski, Diagnosed 2010 , DGM, Germany

    Hans Dieter Olszewski, Diagnosed 2010 , DGM, Germany

  • Laurie Petit-Jean, Diagnosed 2012 , ARSLA, France

    Laurie Petit-Jean, Diagnosed 2012 , ARSLA, France

  • Valdomiro Xavier Honório, Brazil

    Valdomiro Xavier Honório, Brazil

  • Rolf Mauch, Association ALS Switzerland, Diagnosed 2015

    Rolf Mauch, Association ALS Switzerland, Diagnosed 2015

  • Armando González Gómez, ACELA, Colombia

    Armando González Gómez, ACELA, Colombia

  • Susan Anderson, Diagnosed 2014 , Hope Loves Company,  USA

    Susan Anderson, Diagnosed 2014 , Hope Loves Company, USA

  • Daniel Hare

    Daniel Hare

  • Chih Ching Darren Wong, MND Malaysia

    Chih Ching Darren Wong, MND Malaysia

  • Frank "Papa" Taylor, USA

    Frank “Papa” Taylor, USA

  • Karl Hughes, Diagnosed 2010 , IMNDA,  Ireland

    Karl Hughes, Diagnosed 2010 , IMNDA, Ireland

  • Chen Chun-Chin

    Chen Chun-Chin

  • Steven Spencer, Diagnosed 2014 , MND New Zealand

    Steven Spencer, Diagnosed 2014 , MND New Zealand

  • Animesh Kumar, Diagnosed 2013 , Asha Ek Hope Foundation, India

    Animesh Kumar, Diagnosed 2013 , Asha Ek Hope Foundation, India

  • Marcelo Farinelli, Diagnosed 2006, ABrELA, Brazil

    Marcelo Farinelli, Diagnosed 2006, ABrELA, Brazil

  • John Dinon, MND Australia

    John Dinon, MND Australia

  • Jeff Sutherland

    Jeff Sutherland
    jspic

  • Guoqiang Xu, Diagnosed 2016 , Shaanxi ALS Association, China

    Guoqiang Xu, Diagnosed 2016 , Shaanxi ALS Association, China

  • Fabio Carvalho, Associação Pró-Cura da ELA, Brazil

    Fabio Carvalho, Associação Pró-Cura da ELA, Brazil

  • Irene McCaughey, Diagnosed 2011,  MND Australia

    Irene McCaughey, Diagnosed 2011, MND Australia

  • Dick Dayton, USA

    Dick Dayton, USA

  • Wilfried Leusing, Diagnosed 2010 , DGM, Germany

    Wilfried Leusing, Diagnosed 2010 , DGM, Germany

  • Zelina Brito, Diagnosed 2018, Brazil

    Zelina Brito, Diagnosed 2018, Brazil

Learn more about the March of Faces

Latest Tweets

  • Just now

Footer

Subscribe to our Bi-Monthly Newsletter

Sign up to receive updates and to hear what's going on in the International Alliance of ALS/MND Associations.

"*" indicates required fields

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2025 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login